Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin

Intensive Care Medicine

Volumn 29, Issue 5, 2003, Pages 763-769

  Boldt, Joachim ^a   Brenner, Thorsten ^a   Lehmann, Andreas ^a   Lang, Johannes ^a   Kumle, Bernhard ^a   Werling, Christiane ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Cardiac surgery; Gelatin; Hydroxyethyl starch; Kidney function; Kidney specific proteins; Volume replacement

Indexed keywords

ALPHA 1 MICROGLOBULIN; GELATIN; GLUTATHIONE TRANSFERASE; HETASTARCH; N ACETYL BETA GLUCOSAMINIDASE;

AGED; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; HEART SURGERY; HUMAN; INTENSIVE CARE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMA VOLUME; POSTOPERATIVE PERIOD; URINALYSIS;

EID: 0037955534     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1702-6     Document Type: Article

References (29)

1. Marik PE, Iglesias J, Marini B (1997) Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 12:51-55
2. Mythen MG, Webb AR (1994) The role of gut mucosal hypoperfusion in the pathogenesis of postoperative organ dysfunction. Intensive Care Med 20:203-209
3. Warren BB, Durieux ME (1997) Hydroxyethylstarch: safe or not? Anesth Analg 84:206-212
4. Traylor RJ, Pearl R (1996) Crystalloid versus colloid: all colloids are not created equal. Anesth Analg 83:209-212
5. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou C, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620-1622
6. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicenter randomised study. Lancet 357:911-916
7. Peron S, Mouthon L, Guettier C, Brechignac S, Cohen P, Guillevin L (2001) Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 55:408-411
8. De Labarthe A, Jacobs F, Blot F, Glotz D (2001) Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111:417-418
9. Ducke G, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low dose dopamine or low dose-dobutamine? Crit Care Med 22:1919-1925
10. Morgera S, Woydt R, Kern H, Schmutzler M, DeJonge K, Lun A, Rohde W, Konertz W, Kow WJ, Neumayer HM (2002) Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med 30:107-112
11. Chew STH, Newman MF, White WD, Conlon PJ, Saunders AM, Strittmatter WJ, Landolfo K, Grocott HP, Stafford-Smith M (2000) Prelimary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93:325-331
12. Kulka PJ, Tryba M, Zenz M (1996) Preoperative alpha-2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24:947-952
13. Mangos GJ, Brown MA, Chan WY, Horton D, Trew P, Whitworth JA (1995) Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med 25:284-289
14. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194-203
15. Chertow GM, Lazerus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J (1997) Preoperative renal risk stratification. Circulation 95:878-884
16. Lindeman RD (1992) Changes in renal function with aging: implications for treatment. Drugs Aging 2:423-431
17. Jorres A, Kordonouri O, Schiessler A, Hess S, Farke S, Gahl GM, Muller C, Djurup R (1994) Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 18:565-569
18. Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ (1994) Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228:123-132
19. Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G, Grezzana G (1990) Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardithorac Anesth 4:469-473
20. Mantur M, Kemona H, Dabrowsky M, Dabrowska J, Sobolewski S, Prokopowicz J (2000) Alpha1-microglobulin as a marker of proximal tubular damage in urinary tract infection in children. Clin Nephrol 53:283-287
21. Sundberg AGM, Appelkvist EL, Bäckman L, Dallner G (1994) Quantitation of glutathione transferase-Pi in the urine by radioimmunaoassay. Nephron 66:162-169
22. Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF (2000) Urinary excretion of gluthatione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 85:120-126
23. Rahn KH (1991) Acute disturbances of renal function. Chest 100 [Suppl]: 197S-199S
24. Ascione R, Lloyd CT, Underwood MJ (1999) On-pump versus off-pump cronary revascularization: evaluation of renal function. Ann Thorac Surg 68:493-498
25. Moran M, Kapsner C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150-153
26. Chinitz JL, Kim KE, Onesti G, Swartz C (1971) Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med 77:76-87
27. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248-249
28. Iana A, Schwartz D (1994) Renal tubular cellular and molecular events in acute renal failure. Nephron 68:413-418
29. Jungheinrich C, Scharf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethylstarch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 95:544-551